Table II.
Cell viability, % | |||
---|---|---|---|
|
|||
Compound name | 20 μM A2780/CP70 | 40 μM A2780/CP70 | Mean |
(+)-catechin hydrate | 103.0±1.53a | 88.83±3.55a | 95.92a |
(−)-epicatechin | 102.8±3.03a | 73.37±5.76b | 88.1a,b |
Baicalin | 94.87±1.25a | 70.43±5.31b | 82.65a,b |
Ellagic acid | 96.90±2.11a | 64.43±2.38b | 80.67a,b |
Tangeretin | 86.33±3.46a,b | 62.07±8.38b | 74.2b,c |
Nobiletin | 80.27±2.48a,b | 63.08±4.10b | 71.68b,c |
Gallic acid | 82.03±10.66a,b | 41.20±9.24c | 61.62c |
Baicalein | 64.97±7.40b | 15.30±3.01d | 40.13d |
Cisplatin | 25.34±10.76c | 1.92±0.54d | 13.63e |
Data are presented as the mean ± standard error of the mean from three independent experiment. Values marked with different letters are significantly different (at P<0.05) when compared with each other.